| Basics |
ZOETIS INC.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
|
| IPO Date: |
February 1, 2013 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$74.02B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.11 | 1.00%
|
| Avg Daily Range (30 D): |
$2.12 | 1.35%
|
| Avg Daily Range (90 D): |
$2.25 | 1.41%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.46M |
| Avg Daily Volume (30 D): |
2.37M |
| Avg Daily Volume (90 D): |
2.45M |
| Trade Size |
| Avg Trade Size (Sh.): |
96 |
| Avg Trade Size (Sh.) (30 D): |
51 |
| Avg Trade Size (Sh.) (90 D): |
53 |
| Institutional Trades |
| Total Inst.Trades: |
24,784 |
| Avg Inst. Trade: |
$7.67M |
| Avg Inst. Trade (30 D): |
$15.05M |
| Avg Inst. Trade (90 D): |
$15.1M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$32.75M |
| Avg Closing Trade (30 D): |
$82.63M |
| Avg Closing Trade (90 D): |
$72.91M |
| Avg Closing Volume: |
283.42K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$5.58
|
$1.41
|
$1.29
|
|
Diluted EPS
|
$5.57
|
$1.41
|
$1.29
|
|
Revenue
|
$ 9.29B
|
$ 2.22B
|
$ 2.32B
|
|
Gross Profit
|
$ 6.59B
|
$ 1.6B
|
$ 1.61B
|
|
Net Income / Loss
|
$ 2.53B
|
$ 631M
|
$ 581M
|
|
Operating Income / Loss
|
$ 3.2B
|
$ 810M
|
$ 732M
|
|
Cost of Revenue
|
$ 2.7B
|
$ 622M
|
$ 707M
|
|
Net Cash Flow
|
$ -254M
|
$ -266M
|
$ 273M
|
|
PE Ratio
|
30.20
|
|
|
|
